Negative Pressure Wound Therapy After Cesarean Delivery
NCT ID: NCT01637870
Last Updated: 2018-04-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
110 participants
INTERVENTIONAL
2012-08-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is our hypothesis that negative pressure wound systems will decrease the wound infection and complication rate in this high risk population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population
NCT02128997
Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery
NCT03269968
Negative Pressure Wound Therapy in Cesarean Section
NCT02289157
Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial
NCT03009110
Prophylactic Post-Cesarean Incisional Negative-pressure Wound Therapy in Morbidly Obese Patients
NCT02901613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is aimed at determining whether or not the use of a suction device placed on the wound instead of a standard sterile dressing will decrease the prevalence of wound complications and wound infections in women at high risk for post operative complications. The investigators will compare the results from the participants of this study to an existing data set of historical controls who underwent cesarean delivery. The study involves placing a single use, portable negative wound pressure system kept in place while in the hospital after surgery (on average 48-72 hours) in women who meet criteria for increased risk of wound complications. The investigators will then compare the rates of wound infection and wound complications between these two groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Negative pressure pump
Will have the Prevena negative pressure wound system placed at the time of surgery.
Prevena negative pressure wound system
Placement of negative pressure wound system at the time of cesarean delivery for those at increased risk for wound complication
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prevena negative pressure wound system
Placement of negative pressure wound system at the time of cesarean delivery for those at increased risk for wound complication
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a cesarean delivery
* Has one or more of the following conditions:
* BMI \> 30
* Anemia
* Preeclampsia (sever or mild)
* Hemolysis, elevated liver enzymes and low platelets (HELLP)
* Urgent procedure
* Rupture of membranes prior to surgery for \> 4 hours
* Chorioamnionitis
* Hypertension
* Diabetes (Gestational or pre-gestational)
* Dense adhesive disease
Exclusion Criteria
* Unable to give informed consent
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kinetic Concepts, Inc.
INDUSTRY
Abbey Hardy-Fairbanks
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abbey Hardy-Fairbanks
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sara Tikkanen, MD
Role: PRINCIPAL_INVESTIGATOR
University of Iowa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201109727
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.